XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - ValueSet

29,056 resources

By Version

R2: 0
R2B: 0
R3: 1,154
R4: 23,662
R4B: 244
R5: 3,968
R6: 28

By Authority

none: 8,611
hl7: 17,881
ihe: 218
national: 1,286
who: 1,060

By Realm

none: 5,874
au: 87
be: 108
br: 73
ca: 244
ch: 395
cl: 150
cr: 11
cz: 48
de: 680
dk: 475
ee: 66
eu: 349
fi: 4
fr: 810
il: 144
in: 48
it: 92
jp: 71
nl: 958
no: 6
nz: 17
pl: 23
se: 10
tw: 161
uk: 23
us: 13,139
uv: 4,925
vn: 23
other: 5

Start Prev Rows 1200 - 1400 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1046	AZT Meds	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1047	Ferritin	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1048	Knee pain I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1049	Knee pain SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.105	conditions_heartfailure	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1050	Knee pain	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1051	Knee decreased ROM SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1052	Knee effusion I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1054	Knee effusion	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1055	Knee crepitus SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1056	OIA_Antiemetics	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1057	OIA_PDE5is	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1058	OIA_Vitamins	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1059	OIA_Plavix	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1061	OIA_Oral_Contraceptives	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1063	OIA_Topical_Steroids	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1064	OIA_Cough_Cold_Meds	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1065	Antiperspirant aluminum salts	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1066	Antiperspirant anticholinergics	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1067	Antieplieptic medications	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1068	Antidepressant medications	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1069	Urinary incontinence SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1070	Urinary incontinence I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1071	Urinary incontinence	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1073	Hemifacial spasm SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1074	Hemifacial spasm I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1075	Hemifacial spasm	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1076	Spasmodic dysphonia SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1077	Physical therapy procedure SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1078	Occupational therapy SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1079	Hyperhidrosis SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1080	Hyperhidrosis I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1081	Hyperhidrosis	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1082	Tic disorder I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1083	Tic disorder SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1084	Tic disorder	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1085	Esophageal achalasia SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1086	Esophageal achalasia I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1087	Esophageal achalasia	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1088	ET propanolol or primidone	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1089	ET topiramate alprazolam or gabapentin	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.109	CKD stage4above I10	active	2024-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1090	Blephraospasm SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1091	Blepharospasm I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1092	Blepharospasm	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1093	Strabismus SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1094	Strabismus I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1095	Strabismus	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1096	Overactive bladder SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1097	Overactive bladder I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1098	Overactive bladder	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1099	Movement disorders SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.110	CKD stage4above SCT	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1100	Movement disorders I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1101	Movement disorders	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1102	Lateral epicondylitis SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1103	Lateral epicondyltisis I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1104	Lateral epicondylitis	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1105	Plantar fasciitis SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1106	Plantar fasciitis I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1107	Plantar fasciitits	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1108	Cardiac CT SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1109	Cardiac CT CPT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.111	CKD stage4above	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1111	Cardiac CT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1112	Cardiac MRI SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1113	Cardiac MRI CPT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1114	Cardiac MRI	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1115	CT Angiography of Coronary Artery SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1116	CT Angiography of Coronary Artery CPT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1117	CT Angiography of Coronary Artery	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.120	Diabetic ketoacidosis SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.121	Diabetic ketoacidosis	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.146	Long Acting Muscarinic Antagonists (LAMA)	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.159	conditions_COPD I10	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.175	Asthma	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.184	DigTx Virtual Reality Contraindications Visual Impairment	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.186	Beta blockers GDMT for heart failure	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.188	medications_heart failure	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.197	Blood (Serum and Plasma) Potassium	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.214	Type 1 Diabetes Mellitus SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.238	MRA mineralocorticoid receptor antagonists	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.244	MRA Mineralocorticoid Receptor Antagonist Allergy	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.260	UACR SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.263	Pregnancy I10	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.281	Statins Allergy SCT	active	2023-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.282	Statin Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.314	relatedconditions_hyperlipidemia I10	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.337	Migraine I10	active	2023-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.34	Blood pressure panel	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.35	Systolic Blood Pressure	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.367	Trandolapril	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.369	Candesartan	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.377	Valsartan	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.397	eGFR	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.412	Statin Moderate Intensity	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.415	LDL Cholesterol	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.43	Urinalysis	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.434	Insulin	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.437	TZD Thiazolidinediones	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.438	medications_T2DM	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.440	relatedconditions_T2DM SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.442	Blood Glucose	active	2024-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.459	Liver cancer	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.47	ACE inhibitor allergy SCT	active	2022-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.474	Allergy to Tdap Vaccine	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.475	Allergy to Td Vaccine	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.481	medications_hypertension	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.492	Inhaled Corticosteroids Allergy	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.498	Metformin AllergyIntolerance SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.508	Abdominal aortic imaging CPT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.517	Hemoglobin A1c	active	2024-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.518	Drug hypersensitivity I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.519	Drug hypersensitivity SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.520	Drug hypersensitivity	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.521	Diabetic Kidney Disease I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.523	Diabetic kidney disease	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.524	Chronic Hepatitis SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.525	Chronic Hepatitis	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.527	OCS_Prednisone	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.531	Anti IgE Medications	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.532	IL5 Antagonists	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.533	Mast cell stabilizers for asthma	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.534	Vasospastic disease I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.535	Vasospastic disease SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.536	Vasospastic disease	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.537	Hemiplegic and basilar migraine I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.538	Hemiplegic and basilar migraine SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.539	Hemiplegic and basilar migraine	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.540	Peptic ulcer disease I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.541	Peptic ulcer disease SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.542	Peptic ulcer disease	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.544	Bleeding disorder I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.545	Bleeding disorder SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.548	Electronic cigarettes or Vaping	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.549	Bleeding disorder	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.552	Triptans	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.553	CGRP receptor antagonists	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.554	Ditans	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.555	Ergots	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.556	Migraine specific NSAIDs	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.557	OTC migraine analgesics	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.559	medications_migraine_acute	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.560	relatedconditions_migraine I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.561	conditions_migraine	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.562	relatedconditions_migraine SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.563	relatedconditions_migraine	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.564	Triptan Allergy Intolerance SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.565	Triptan Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.566	Ischemic bowel disease SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.567	Ischemic bowel disease I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.568	Ischemic bowel disease	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.573	conditions_hyperlipidemia I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.574	conditions_hyperlipidemia SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.575	conditions_hyperlipidemia	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.578	PIM_Schedule V	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.580	PIM_Acarbose	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.582	PIM_Dulaglutide	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.583	PIM_Glimepiride	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.585	PIM_Glucophage	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.587	PIM_Glucovance	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.588	Glyburide PIM	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.590	Alpha glucosidase inhibitors	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.592	Azotemia	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.594	Intolerance to ARB SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.595	ICS Low	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.596	ICS Medium	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.597	ICS High	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.598	Low Dose ICS Formoterol	active	2024-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.600	PIM_Vitamin B12 Level_LOINC	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.601	PIM_Vitamin B12 Level_CPT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.604	PIM_Glyburide	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.605	PIM_Pioglitazone	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.606	PIM_Semaglutide	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.607	PIM_Linagliptin	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.609	Macrolide_Azithromycin	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.61	Secondary antihypertensives	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.610	Long Acting Beta Agonists (LABA) Non_Formoterol	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.612	Wolff Parkinson White SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.613	Wolff Parkinson White I10	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.614	Wolff Parkinson White	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.615	medications_Asthma	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.619	ICS_LABA_LAMA	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.620	Low Dose ICS_LABA_Non Formoterol	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.621	Medium ICS_LABA Non Formoterol	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.623	LAMA Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.624	LABA Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.625	BetaBlock NonCS Secondary Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.626	Eplerenone Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.627	Spironolactone Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.628	SGLT2 Inhibitors Allergy SCT	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.629	PIM_Refill_Request_Antilipemics_LFTs	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.630	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.631	Pneumococcal Vaccine Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.632	Meglitinides Allergy SCT	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.633	DPP4i Allergy SCT	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.635	Alpha_glucosidase inhibitors allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.636	Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.637	Insulins Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.638	TZD Allergy SCT	active	2024-04	us	hl7